Efficacy, onset of action and patient satisfaction with zolmitriptan nasal spray: Phases I and II of the REALIZE study

被引：0

作者：

Gawel, M. ^{[1
]}

Aschoff, J. ^{[2
]}

May, A. ^{[3
]}

Charlesworth, B. R. ^{[4
]}

机构：

[1] Sunnybrook & Womens Coll Hlth Sci Ctr, Toronto, ON, Canada

[2] Univ Ulm, D-89069 Ulm, Germany

[3] Univ Regensburg, D-8400 Regensburg, Germany

[4] AstraZeneca, Macclesfield, Cheshire, England

来源：

EUROPEAN JOURNAL OF NEUROLOGY | 2004年 / 11卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：96 / 96

页数：1

共 37 条

[21] Study Design to Evaluate the Efficacy and Safety of Zolmitriptan Nasal Spray (ZNS) for the Acute Treatment of Migraine Headaches in Pediatric Patients Ages 6 to 11
Hershey, A. D.
Khanna, S.
Modi, N.
Gupta, S.
Wray, H.
Rubens, R.
HEADACHE, 2017, 57 : 195 - 195
[22] Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis
Wang, D
Duyck, F
Smitz, J
Clement, P
ALLERGY, 1998, 53 (04) : 375 - 382
[23] Patient satisfaction and sensory attributes of Mometasone Furoate delivered by a novel nasal spray device: an observational, real-world study
Sorano, Alessandra
Allegrini, Chiara
Buttini, Francesca
Lavorini, Federico
EUROPEAN RESPIRATORY JOURNAL, 2024, 64
[24] Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ)
Winner, Paul
Farkas, Viktor
Stillova, Helena
Woodruff, Brian
Liss, Charlie
Lillieborg, Stefan
Raines, Shane
HEADACHE, 2016, 56 (07): : 1107 - 1119
[25] Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: A placebo-controlled study
Meltzer, EO
CLINICAL THERAPEUTICS, 2002, 24 (06) : 942 - 952
[26] Prospective survey on patient satisfaction and quality-of-life impact concerning the administration of fentanyl pectin nasal spray for breakthrough pain in cancer: QualipeC study.
Delgado, Ignacio
Anton-Aparicio, Luis
Poulain, Philippe
Serrie, Alain
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[27] A randomized, double-blind, placebo-controlled, controlled antigen delivery study of the onset of action of aerosolized triamcinolone acetonide nasal spray in subjects with ragweed-induced allergic rhinitis
Day, JH
Buckeridge, DL
Clark, RH
Briscoe, MP
Phillips, R
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 97 (05) : 1050 - 1057
[28] EFFICACY, TOLERABILITY, AND SPEED OF ONSET OF FENTANYL PECTIN NASAL SPRAY IN THE TREATMENT OF BREAKTHROUGH CANCER PAIN: A MULTICENTER, PLACEBO- CONTROLLED, DOUBLE-BLIND, TWO-PHASE CROSSOVER STUDY
Smith, Carrie
Gabrail, Nashat
Burton, Allen
Reyes, Evangeline
Nguyen, An
Taylor, Donald
ONCOLOGY NURSING FORUM, 2011, 38 (02) : E174 - E174
[29] Patient Satisfaction and Sensory Attributes of Nasal Spray Treatments of Olopatadine Hydrochloride/Mometasone Furoate Monohydrate and Azelastine Hydrochloride/Fluticasone Propionate for Allergic Rhinitis in Australia - An Observational Real-World Clinical Study
Fifer, Simon
Toh, Lili
Barkate, Hanmant
Aggarwal, Vineet
Borade, Dhammraj
Gordonsmith, Roger Hereward
Wu, Wen
Morgan, Claire
Young, Katherine
PATIENT PREFERENCE AND ADHERENCE, 2023, 17 : 141 - 151
[30] The efficacy, tolerability, and speed of onset of fentanyl pectin nasal spray (FPNS) in the treatment of breakthrough cancer pain (BTCP): A multicenter, placebo-controlled, double-blind, two-phase crossover study
Gabrail, N. Y.
Burton, A. W.
Reyes, E.
Nguyen, A.
Taylor, D. R.
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)

← 1 2 3 4 →